日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas

帕博利珠单抗治疗进展性转移性嗜铬细胞瘤和副神经节瘤患者的II期临床试验

Jimenez, Camilo; Subbiah, Vivek; Stephen, Bettzy; Ma, Junsheng; Milton, Denai; Xu, Mingxuan; Zarifa, Abdualrazzak; Akhmedzhanov, Fechukwu Omolara; Tsimberidou, Apostolia; Habra, Mouhammed Amir; Rodon Anhert, Jordi; Fu, Siqing; Naing, Aung